Product ID |
Product Name |
CAS# |
Purity |
Y3166323 |
2-(2,2-Difluoroethyl)propanedioic acid |
1204333-56-1 |
95% |
Y3317122 |
3,5-Dibromo-9H-carbazole |
133753-43-2 |
95% |
Y1343469 |
methyl 4-acetamido-2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxylate |
132976-81-9 |
95% |
Y1343587 |
2-butoxy-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-amine |
866268-28-2 |
95% |
Y3306885 |
Ethyl (1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxylate |
2228937-00-4 |
95% |
Y3307336 |
4,4'-(1,4-Phenylene)bis[1-(4-methylphenyl)-2,6-diphenylpyridinium] ditetrafluoroborate |
121188-22-5 |
90% |
Y3307538 |
N-[(Propan-2-yloxy)methyl]pyridine-3-carboxamide |
164299-78-9 |
96% |
Y3304689 |
1-[2-Phenyl-1-(pyridin-2-yl)ethenyl]-1H-1,2,3-benzotriazole |
300684-28-0 |
98% |
Y3307511 |
1-[(8-Methylindolizin-2-yl)methyl]-1H-1,2,3-benzotriazole |
305862-01-5 |
99% |
Y1343197 |
(R)-methyl 3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoate |
837430-13-4 |
96% |
Y3289603 |
5-Aminolevulinic acid-4-13C (hydrochloride) |
129720-94-1 |
98% |
Y3167360 |
84-B10 |
698346-43-9 |
99.62% |
Y3309100 |
HHS-0701 |
2851993-91-2 |
97% |
Y3308215 |
MUC1, mucin core |
149205-73-2 |
98.00% |
Y3169189 |
PROTAC BRD4 Degrader-10 |
2417370-49-9 |
99% |
Y3285980 |
LLO (91-99) |
137856-41-8 |
99% |
Y3311830 |
Brexpiprazole S-oxide-d8 |
2748605-29-8 |
98.72% |
Y3288305 |
BRD4 Inhibitor-20 |
2490311-14-1 |
99% |
Y3306269 |
Biotin-TAT (47-57) |
1231898-25-1 |
99.35% |
Y3114765 |
m-PEG24-azide |
2563873-82-3 |
98% |
Y3162131 |
1,5-dimethyl-1H-imidazole-4-carboxylic acid hydrochloride |
2758001-02-2 |
95% |
Y3163719 |
lithium(1+)ion2-(2-methylpyridin-4-yl)acetate |
2287330-84-9 |
95% |
Y3163720 |
1-bromo-4-methoxybutan-2-one |
83821-00-5 |
95% |
Y3306220 |
2-(azidomethyl)pyridine-3-carboxylicacidhydrochloride |
2408971-84-4 |
95% |
Y3114866 |
MIL-101-Cr |
869288-09-5 |
N/A |
Y3161882 |
2-{[(tert-butoxy)carbonyl]amino}-3-(1,5-dimethyl-1H-pyrazol-4-yl)propanoic acid |
1379838-29-5 |
95% |
Y3114766 |
dCeMM3 |
311787-85-6 |
95% |
Y3290120 |
dCeMM4 |
1281683-44-0 |
99% |
Y3307652 |
PPTN |
1160271-30-6 |
100% |
Y3163477 |
2-(4-hydroxy-3-methylphenyl)acetonitrile |
73653-24-4 |
95% |
Y3169625 |
3,5-diiodo-4-methyl-1H-pyrazole |
866639-16-9 |
95% |
Y3316567 |
Methyl 5-chloro-6-fluoropicolinate |
1214335-09-7 |
97% |
Y3164347 |
5-iodopentanoicacid |
19448-36-3 |
95% |
Y3286487 |
methyl2-(1-aminocyclopropyl)benzoatehydrochloride |
2418723-13-2 |
95% |
Y3164477 |
1-(2-{[(tert-butoxy)carbonyl]amino}ethyl)-1H-imidazole-4-carboxylicacid |
1696030-74-6 |
95% |
Y3164478 |
5-bromo-3-hydroxy-1-methyl-1,2-dihydropyridin-2-one |
1706752-65-9 |
95% |
Y3115027 |
methyl 3-formyl-1,2-oxazole-5-carboxylate |
1369362-27-5 |
95% |
Y3169362 |
methyl 3-formyl-1,2-thiazole-5-carboxylate |
2763750-63-4 |
95% |
Y3164042 |
6-(difluoromethyl)-2-azaspiro[3.3]heptanehydrochloride |
2411265-54-6 |
95% |
Y3163784 |
1,1-difluorospiro[2.4]heptane-5-carboxylic acid |
2248395-44-8 |
95% |
Y3163937 |
4,4,5,5-tetramethyl-2-[(1E)-3,3,3-trifluoroprop-1-en-1-yl]-1,3,2-dioxaborolane |
2130860-50-1 |
93% |
Y3170355 |
2-(4-bromo-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2264017-64-1 |
95% |
Y3161966 |
3-{[(tert-butoxy)carbonyl]amino}-2-fluorobenzoic acid |
1517265-62-1 |
95% |
Y3163944 |
tert-butyl N-[(1S)-1-{[(1S)-2-[(2S,4S)-4-amino-2-{[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl}pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]carbamoyl}ethyl]-N-methylcarbamate |
1613552-03-6 |
95% |
Y3164048 |
2-{4-[(tert-butoxy)carbonyl]-1,4-oxazepan-6-yl}aceticacid |
2418669-31-3 |
95% |
Y3112192 |
N-(5-Fluoro-2-(4-methylpiperazin-1-yl)phenyl)-2-methylthiazole-4-carboxamide |
1333666-88-8 |
98% |
Y3112043 |
methyl2-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate |
2201133-24-4 |
98% |
Y3112093 |
(4-(Ethoxycarbonyl)cyclohex-1-en-1-yl)boronic acid |
1443112-50-2 |
97% |
Y3112063 |
2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile |
2172654-65-6 |
97% |
Y3133793 |
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]sulfanyl}acetic acid |
2378582-26-2 |
95% |
Y3178097 |
2-bromo-6-(2-fluoropropan-2-yl)pyridine |
1189746-38-0 |
95% |
Y3165368 |
6-(1,1-difluoroethyl)pyridin-3-amine |
1211584-70-1 |
95% |
Y3179872 |
3-bromo-2-(1,1-difluoroethyl)pyridine |
1825299-11-3 |
95% |
Y3170641 |
3-(1,1-difluoroethyl)pyridin-2-amine |
2361713-18-8 |
95% |
Y3174239 |
5-bromo-2-(2-fluoropropan-2-yl)pyrimidine |
1795452-07-1 |
95% |
Y3179881 |
4-chloro-6-(1,1-difluoroethyl)pyrimidine |
1289106-68-8 |
95% |
Y3174240 |
[6-(1,1-difluoroethyl)pyridin-2-yl]methanol |
2260932-23-6 |
95% |
Y3170643 |
[5-(1,1-difluoroethyl)pyridin-2-yl]methanol |
2377031-03-1 |
95% |
Y3293653 |
(R)-N-(1-(benzyl(methyl)amino)propan-2-yl)-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide |
1418293-40-9 |
99% |
Y3310145 |
5-tert-butyl 3-ethyl 7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-3,5(6H)-dicarboxylate |
1251004-02-0 |
95% |
Y3170647 |
tert-butyl 3-fluoro-2-methylbenzoate |
1936169-16-2 |
95% |
Y3172452 |
Pomalidomide-amino-PEG5-NH2 hydrochloride |
2421217-05-0 |
99% |
Y3114767 |
(2S,4R)-1-((S)-2-(6-aminohexanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
2170695-20-0 |
95% |
Y3293756 |
2-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)phenoxy)acetic acid |
2633633-12-0 |
98% |
Y3293735 |
2-(2,6-dioxopiperidin-3-yl)-3-oxoisoindoline-5-sulfonyl fluoride |
2803819-61-4 |
95%+ |
Y3307451 |
2,6-Piperidinedione, 3-(4-hydroxyphenyl) |
2758531-21-2 |
95% |
Y3163881 |
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan |
2495742-34-0 |
98% |
Y3295786 |
Lorundrostat |
1820940-17-7 |
99% |
Y3114948 |
TGFßRI-IN-3 |
2763602-67-9 |
98% |
Y3308717 |
gp120-a4ß7 binding inhibitor 11 |
869474-87-3 |
97% |
Y3163882 |
Wnt/ß-catenin agonist 4 |
912784-79-3 |
96% |
Y3160642 |
N4-propylpyridine-3,4-diamine |
438554-28-0 |
95% |
Y3307929 |
Ethyl 1-propanesulfonate |
91284-43-4 |
95% |
Y3164387 |
(cuban-1-yl)methanesulfonylchloride |
1620821-39-7 |
95% |
Y3114856 |
4,4,5,5-tetramethyl-2-[(oxolan-3-ylidene)methyl]-1,3,2-dioxaborolane |
2246914-68-9 |
98% |
Y3297623 |
BoNT-IN-2 |
354784-03-5 |
95% |
Y3169186 |
PU141 |
168334-34-7 |
99% |
Y3308028 |
Quinacainol |
86073-85-0 |
99% |
Y3290516 |
SC-435 |
289037-67-8 |
98% |
Y3310208 |
GV-150013 |
167355-22-8 |
98% |
Y3310671 |
CCCI-01 |
215778-97-5 |
100% |
Y3291022 |
N-(4-chlorophenyl)-5,5-difluoro-1-[3-fluoro-5-(pyridin-4-yl)benzoyl]piperidine-3-carboxamide |
1922098-90-5 |
99% |
Y3306720 |
CCTA-1523 |
1616271-41-0 |
99% |
Y3304590 |
CID-5056270 |
681173-76-2 |
99% |
Y3308445 |
DSM421 |
2011769-21-2 |
99% |
Y3311707 |
Granotapide |
594842-13-4 |
99% |
Y3309302 |
Rho-Kinase-IN-3 |
864082-23-5 |
98% |
Y3304620 |
GW-493838 |
253124-46-8 |
100% |
Y3309614 |
K-8012 |
1346513-17-4 |
98% |
Y3309422 |
L 756423 |
216863-66-0 |
98% |
Y3311818 |
L-796,778 |
217480-25-6 |
95% |
Y3304660 |
LY-402913 |
334970-65-9 |
100% |
Y3162144 |
Nrf2-Activator-12G |
1554271-18-9 |
99% |
Y3307628 |
P22074 |
90680-28-7 |
100% |
Y3307136 |
Palatrigine |
98410-36-7 |
98% |
Y3287204 |
Bemfivastatin |
805241-79-6 |
99% |
Y3287331 |
PDE9-IN-1 |
2305087-92-5 |
99% |
Y3317245 |
BY27 |
2247236-59-3 |
100% |
Y3305690 |
AMPA receptor modulator-1 |
2036074-41-4 |
98% |
Y3310286 |
ZEN-3862 |
1952264-33-3 |
97% |